Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients (0.8%) than among comparator-treated patients (0.4%) in clinical trials
The chemical compound (tirzepatide) is the same molecule, but pharmaceutical-grade and research-grade products differ in manufacturing standards, formulation, and regulatory status
However, it might also have more gastrointestinal side effects and a slightly higher risk of pancreatitis
Of note, solid evidence from randomized clinical trials (RCTs) confirms the efficacy and safety of OW GLP-1RAs as a complementary treatment to metformin (3, 4)
Our team looks closely at metabolic health, hormones and the bigger picture,e so care feels more informed and less confusing